Q1 2024 13F Holders as of 31 Mar 2024
-
Type / Class
-
Equity / Common Shares
-
Shares outstanding
-
2,587,950
-
Total 13F shares
-
977,602
-
Share change
-
-131,033
-
Total reported value
-
$1,623,107
-
Price per share
-
$1.66
-
Number of holders
-
20
-
Value change
-
-$345,174
-
Number of buys
-
4
-
Number of sells
-
10
Institutional Holders of Aptose Biosciences Inc. - Common Shares (APTO) as of Q1 2024
As of 31 Mar 2024 Aptose Biosciences Inc. - Common Shares (APTO) had 20 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 977,602 shares of stock of the company.
Largest 10 holders included DRW Securities, LLC, Sigma Planning Corp, Nantahala Capital Management, LLC, MORGAN STANLEY, CITADEL ADVISORS LLC, Cetera Investment Advisers, Texas Capital Bank Wealth Management Services Inc, PDS Planning, Inc, US BANCORP \DE\, and Gleason Group, Inc..
This table shows 20 institutional shareholders of the security as of 31 Mar 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.